creatine
metaboliteCreatine dysregulation reflects impaired myocardial energetics in acute coronary syndrome and recovery, marking cardiomyocyte ischemic injury and metabolic restoration.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleMyocardial high-energy phosphate metabolism; downregulated in ACS; relates to cardiac energy depletion and recovery phase.
Also acts inSystemic / off-pathway
Druggability
Not assessed (no mapped human gene target).
Type I vs non-Type I discrimination
ScoresNon-Type-I-associated
R — rupture / Type-I—
C — non-Type-I58
A — assay feasibility42
E — evidence strength—
T1DI (composite)—
Specificity differential (R−C)-43.3
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossmag 2
2hypovolemia / dehydrationmag 2
2tachyarrhythmiamag 1
2hypoxemia / respiratory failuremag 2
2hypertensive emergencymag 2
2high-demand / peri-operative stressmag 1
3sudden cardiac deathmag 2
4aPCI-related periproceduralmag 2
4bstent thrombosismag 2
4cin-stent restenosismag 1
5CABG-relatedmag 2
Coverage: 12/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 21 supporting references. See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(3)
- Targeted arginine metabolomics combined with metagenomics revealed the potential mechanism of Pueraria lobata extract in treating myocardial infarction.Journal of chromatography. A · 2024 · PMID 38387153 · doi
- Serum Metabolomic Analysis Suggests Impairment of Myocardial Energy Production in Takotsubo Syndrome.Metabolites · 2021 · PMID 34357333 · doi
- Urinary metabonomic study of patients with acute coronary syndrome using UPLC-QTOF/MS.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2018 · PMID 30316136 · doi